Healthcare · NYSE/NASDAQ: COR
Cencora, Inc.
Medical Distribution
Market Cap $54.76B
Verdict: High
Quality Scores
Multi-Bagger
72/100
Compounder Quality
85/100
Management Credibility
90/100
Governance
72/100
Cash Flow Quality
92/100
AI Summary
Cencora, Inc. (formerly AmerisourceBergen) has undergone a massive scale transformation over the last decade, with revenues jumping from approximately $37B to over $320B. Despite operating on razor-thin margins characteristic of the pharmaceutical distribution oligopoly, the company maintains a critical role in the healthcare supply chain. A significant $6.1B operating loss in 2020 related to opioid litigation settlements represents a major historical blemish, but the underlying business remains a cash-flow powerhouse with consistent operational execution. The company’s focus has shifted…
Top Opportunities
- Massive revenue scale exceeding $300B
- Essential role in global healthcare infrastructure
- Strong historical Cash Flow from Operations
Top Risks
- Extremely thin net profit margins (<1%)
- Significant litigation liabilities related to opioids
- Period of negative equity due to legal accruals
Latest report: Read the annual report summary →
Unlock the full report
Full sections, financial charts, AI chat and PDF export are available with Premium.